Serife Demir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Serife Demir has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Burcu Öztürk Şahin
Department of Pulmonary Medicine, University of Health Sciences Gulhane School of Medicine Ankara, Türkiye
2 shared publications - Ipek Kivilcim Oguzulgen
Department of Chest Diseases, Gazi University Faculty of Medicine, Ankara, Türkiye
2 shared publications - Nilgün Yılmaz Demirci
Department of Chest Diseases, Gazi University Faculty of Medicine, Ankara, Turkey
2 shared publications - Ahmet Selim Yurdakul
Gazi Univ, Fac Med, Dept Pulm, Ankara, Turkiye
1 shared publication - Beyza Çiftci
Gazi Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Mevlana St 89, TR-06560 Ankara, Turkiye
1 shared publication Gonca Erbas
Department of Radiology, Gazi University Faculty of Medicine, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 22 September 2023
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 261-272
Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.
- 22 September 2023
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 261-272
Open AccessRisk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care center.Materials and Methods: In this observational study, based on a survey of 1.977 COVID-19 patients hospitalized from April 2020 to January 2021, a retrospective assessment was carried out on 1.050 individuals who were reachable via telephone to determine their eligibility for meeting the inclusion criteria.Results: The data of 256 patients who reported at least one persistent symptom were analyzed. Long COVID prevalence was 24.3%. Among 256 patients (median age 52.8; 52.7% female; 56.63% had at least one comorbidity), dyspnea, fatigue, arthralgia-myalgia, cough, and back pain were the most common post-acute sequelae of COVID-19 (42.4%; 28.29%; 16.33%; 13.15% and 7.17%, respectively). The risk factors for the persistence of dyspnea included having lung diseases such as chronic obstructive pulmonary disease, a history of intensive care support, the requirement for long-term oxygen therapy, and a history of cytokine storm (p= 0.024, p= 0.026, p< 0.001, p= 0.036, p= 0.005, respectively). The correlation between lung involvement with post-discharge cough (p= 0.041) and dizziness (p= 0.038) was significant. No correlation between the symptoms with the severity of acute infection, age, and gender was found. When a multivariate regression analysis was conducted on the most common long COVID-related symptoms, several independent risk factors were identified. These included having lung disease for dyspnea (OR 5.81, 95% CI 1.08-31.07, p= 0.04); length of hospital stay for myalgia (OR 1.034, 95% CI 1.004-1.065, p= 0.024); and pulmonary involvement of over 50% during COVID-19 infection for cough (OR 3.793, 95% CI 1.184-12.147, p= 0.025).Conclusion: COVID-19 survivors will require significant healthcare services due to their prolonged symptoms. We hope that our findings will guide the management of these patients in clinical settings towards best practices.
- Open Access
- 21 July 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (4) , 231-234
Granulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension
Anthracosis,anthracofibrosis,fibrosis mediastinitis,biomass exposure,pulmonary hypertension
- 21 July 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (4) , 231-234
Open AccessGranulomatous Mediastinitis: A Rare Cause of Pulmonary Hypertension
Anthracosis,anthracofibrosis,fibrosis mediastinitis,biomass exposure,pulmonary hypertension